CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-30 | Flynn James E 10% owner | Conversion | +1,572,960 | 1,572,960 | ||
| 2021-03-30 | Flynn James E 10% owner | Conversion | +1,301,626 | 2,874,586 | ||
| 2021-03-30 | Flynn James E 10% owner | Conversion | +433,551 | 3,308,137 | ||
| 2021-03-30 | Flynn James E 10% owner | Purchase | +625,000 | $16.00 | $10.0M | 3,933,137 |
| 2021-03-30 | Flynn James E 10% owner | Conversion · Series B-1 Preferred Stock | −1,572,960 | 0 | ||
| 2021-03-30 | Flynn James E 10% owner | Conversion · Series B-2 Preferred Stock | −1,301,626 | 0 | ||
| 2021-03-30 | Flynn James E 10% owner | Conversion · Series C Preferred Stock | −433,551 | 0 | ||
| 2021-03-30 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% owner | Conversion | +681,812 | 681,812 | ||
| 2021-03-30 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% owner | Conversion · Series C Preferred Stock | −681,812 | 0 |
Page 26 of 26 · 509 trades